Immunomedics, Inc.
Sector: Health Technology
Industry: Biotechnology
87.86
0
(0%)
Volume:
0
52 week range:
8.8 - 87.93
Market Cap:
20.309B
Company Description:
Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.